In silico prediction of spleen tyrosine kinase inhibitors using machine learning approaches and an optimized molecular descriptor subset generated by recursive feature elimination method
- 1 May 2013
- journal article
- Published by Elsevier BV in Computers in Biology and Medicine
- Vol. 43 (4), 395-404
- https://doi.org/10.1016/j.compbiomed.2013.01.015
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: A three‐month randomized, placebo‐controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agentsArthritis & Rheumatism, 2010
- Syk kinase inhibitors for rheumatoid arthritis: Trials and tribulationsArthritis & Rheumatism, 2010
- Rheumatoid arthritisThe Lancet, 2010
- Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2010
- Prospective new biological therapies for rheumatoid arthritisAutoimmunity Reviews, 2009
- Cytokines as Targets for Anti‐inflammatory AgentsAnnals of the New York Academy of Sciences, 2009
- Prediction of novel and selective TNF-alpha converting enzyme (TACE) inhibitors and characterization of correlative molecular descriptors by machine learning approachesJournal of Molecular Graphics and Modelling, 2009
- Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseasesArthritis Research & Therapy, 2009
- New therapies for treatment of rheumatoid arthritisThe Lancet, 2007
- Evolving concepts of rheumatoid arthritisNature, 2003